Latvia Pilots Free Antibiotic Distribution to Combat Resistance and Treatment Gaps

In Latvia, a patient leaves the hospital after treatment, prescribed a course of antibiotics to finish at home. But the pharmacy is across town. Money is tight after missing work. The pills sit unfilled, or worse, run out early when the patient can't afford to refill them. The bacteria, meanwhile, adapts. It survives the incomplete assault. It becomes resistant. This cycle—poverty and exhaustion interrupting treatment, resistance spreading—is what the Latvian Ministry of Health is now trying to break.

Starting this month, the Pauls Stradiņš Clinical University Hospital began handing patients their full antibiotic course at discharge, free of charge. No trip to the pharmacy. No bill. A patient might receive anywhere from a single day's worth to a full month of tablets, depending on what their doctor prescribed. The medication goes home in their pocket. The barrier dissolves.

The problem the program addresses is straightforward but urgent. Antimicrobial resistance—bacteria that no longer respond to the drugs meant to kill them—has become a global threat. It happens when treatment is incomplete or misused. A patient takes antibiotics for three days, feels better, stops taking them. The weakest bacteria die; the strongest survive and multiply. Or someone cannot afford the full course and takes half-doses to stretch it out. Either way, the bacteria learn to resist. The next time that person or someone else gets infected, the old medication fails. Doctors must reach for stronger drugs. Eventually, there may be no drugs left that work.

In Latvia, as in many countries, this resistance is rising. The Ministry of Health identified a specific driver: people simply do not complete their prescribed courses. Some lack the money. Others lack the energy or mobility to reach a pharmacy after an illness. Some forget. Some prioritize other expenses. The result is incomplete treatment, and incomplete treatment breeds resistance.

The new scheme removes these obstacles. A person discharged from Stradiņš Hospital who has been prescribed outpatient antibiotics receives them before leaving. The hospital bears the cost. The patient bears no burden. Professor Uģis Dumpis, who heads the Antimicrobial Resistance Center at the hospital, noted that the program currently covers tablet antibiotics only. But if the pilot succeeds, the model could expand to include intravenous medications that patients could administer at home, further reducing the need for repeated hospital visits.

The logistics are built to match the treatment. For short courses—less than a week—patients simply call their family doctor when finished. For longer treatments, the hospital creates an individual monitoring plan, including follow-up tests and specialist check-ins to ensure the medication is working and the patient is tolerating it. This transforms the discharge moment from an ending into a bridge: the hospital does not simply release the patient; it equips and tracks them.

The Ministry and hospital are now measuring what happens. They want to know how many patients actually use this service, whether hospital readmissions drop, and whether people stick to their treatment plans better when the friction is removed. These metrics will determine whether the program spreads to other hospitals across Latvia. What began as a practical solution to a local problem—getting antibiotics into the hands of people who need them—may become a model for how a small country fights a global threat. The results will tell whether removing poverty and inconvenience from medicine is enough to restore the power of drugs that, for decades, we have taken for granted.